Elevated S100B levels, along with neurofilament light chains (NfL), have been identified as key indicators for predicting delirium and unfavorable outcomes in patients suffering from septic encephalopathy, underscoring their potential as specific and prognostic biomarkers for this condition [115]. This evidence concerns the gene S100B and delirium.